Olivier Delalande

Fondation Ophtalmologique Adolphe de Rothschild

Papers

1

Total Citations

61

H-Index

1

About

Olivier Delalande is a pioneering neurosurgeon whose research focuses on the surgical treatment of drug-resistant epilepsy, particularly in pediatric populations. His major contributions center on the development of minimally invasive techniques for hypothalamic hamartomas (HH), a congenital brain lesion that can cause severe, refractory seizures. Delalande’s seminal work, "Endoscopic disconnection of hypothalamic hamartomas: safety and feasibility of robot-assisted, thulium laser–based procedures" (2014, 61 citations), revolutionized the field by demonstrating that a disconnection procedure—rather than complete lesion removal—is safer and equally effective. By integrating robotic assistance and thulium laser technology, he enhanced precision and reduced morbidity, offering new hope for children with drug-resistant epilepsy. This landmark study has been widely cited, influencing global neurosurgical protocols. Delalande’s innovative approach has not only improved surgical outcomes but also expanded the therapeutic landscape for HH, making him a key figure in pediatric epilepsy surgery. His work exemplifies how technological integration can transform complex neurosurgical challenges into manageable, life-changing interventions.

Research Focus

Key Achievements

1
H-Index
1
Papers
61
Total Citations
61
Avg Citations/Paper
🏆 Most Cited Paper
Endoscopic disconnection of hypothalamic hamartomas: safety and feasibility of robot-assisted, thulium laser–based procedures
61 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Fondation Ophtalmologique Adolphe de Rothschild

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago